Chimeric Antigen Receptor T Cells in Multiple Myeloma

被引：1
|
作者：
Shah, Parth [1 ,2 ,4 ]
Sperling, Adam S. [2 ,3 ]
机构：
[1] Dartmouth Canc Ctr, Dept Hematol, 1 Med Ctr Dr, Lebanon, NH 03750 USA
[2] Dana Farber Canc Inst, Med Oncol, 450 Brookline Ave, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Div Hematol, 75 Francis St, Boston, MA 02115 USA
[4] 1 Med Ctr Dr, Lebanon, NH 03750 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2023年 / 37卷 / 06期
关键词：
Multiple myeloma; CAR-T; BCMA; GPRC5D; BiTEs; THERAPY; BCMA; MALIGNANCIES; MATURATION; ANTIBODY; COMBINATION; TRANSPLANT; EXPRESSION; PHASE-1; FUSION;
D O I：
10.1016/j.hoc.2023.05.008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1089 / 1105
页数：17
相关论文
共 50 条
  • [31] Chimeric antigen receptor T-cell therapy for multiple myeloma
    Naoki Hosen
    International Journal of Hematology, 2020, 111 : 530 - 534
  • [32] Characterization of novel dual tandem CD19/BCMA chimeric antigen receptor T cells to potentially treat multiple myeloma
    Kang, Liqing
    Zhang, Jian
    Li, Minghao
    Xu, Nan
    Qi, Wei
    Tan, Jingwen
    Lou, Xiaoyan
    Yu, Zhou
    Sun, Juanjuan
    Wang, Zhenkun
    Fu, Chengcheng
    Tang, Xiaowen
    Dai, Haiping
    Chen, Jia
    Wu, Depei
    Yu, Lei
    BIOMARKER RESEARCH, 2020, 8 (01)
  • [33] Paving the Way toward Successful Multiple Myeloma Treatment: Chimeric Antigen Receptor T-Cell Therapy
    Grywalska, Ewelina
    Sosnowska-Pasiarska, Barbara
    Smok-Kalwat, Jolanta
    Pasiarski, Marcin
    Niedzwiedzka-Rystwej, Paulina
    Rolinski, Jacek
    CELLS, 2020, 9 (04)
  • [34] Characterization of the Therapeutic Effects of Novel Chimeric Antigen Receptor T Cells Targeting CD38 on Multiple Myeloma
    Li, Xiaorui
    Feng, Yaru
    Shang, Fengqin
    Yu, Zhuoying
    Wang, Tieshan
    Zhang, Jing
    Song, Zhiru
    Wang, Ping
    Shi, Bingjie
    Wang, Jianxun
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [35] Chimeric antigen receptor T cells march into T cell malignancies
    Tang, Jie
    Zhao, Xudong
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (14) : 13459 - 13475
  • [36] Chimeric antigen receptor T cell therapy in multiple myeloma: promise and challenges
    Dhakal, Binod
    Hari, Parameswaran N.
    Usmani, Saad Z.
    Hamadani, Mehdi
    BONE MARROW TRANSPLANTATION, 2021, 56 (01) : 9 - 19
  • [37] The promise of chimeric antigen receptor (CAR) T cell therapy in multiple myeloma
    Feinberg, Daniel
    Paul, Barry
    Kang, Yubin
    CELLULAR IMMUNOLOGY, 2019, 345
  • [38] Cytotoxicity and exhaustion markers of chimeric antigen receptor T cells targeting BCMA in multiple myeloma cell lines between patients and healthy donors
    Prasongtanakij, Somsak
    Preedagasamzin, Sarinthip
    Jittorntrum, Bunyada
    Anurathapan, Usanarat
    Puavilai, Teeraya
    Niparuck, Pimjai
    Chantrathammachart, Pichika
    Piyajaroenkij, Thanakrit
    Uaesoontrachoon, Kitipong
    Uchibori, Ryosuke
    Ozawa, Keiya
    Ohmine, Ken
    Hongeng, Suradej
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (02) : 248 - 256
  • [39] Advances in chimeric antigen receptor T cells
    Beyar-Katz, Ofrat
    Gill, Saar
    CURRENT OPINION IN HEMATOLOGY, 2020, 27 (06) : 368 - 377
  • [40] Chimeric Antigen Receptor (CAR) therapy for multiple myeloma
    Atanackovic, Djordje
    Radhakrishnan, Sabarinath V.
    Bhardwaj, Neelam
    Luetkens, Tim
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 172 (05) : 685 - 698
12345